Table 3.
Factors | Complete compliance |
Tamiflu consumption |
||
---|---|---|---|---|
Odds ratio | 95% CI | Odds ratio | 95% CI | |
Gender | n = 198; R2 = 0.49 | n = 226, R2 = 0.29 | ||
Female | –c | –c | –c | –c |
Male | 1.10 | 0.46–2.65 | 2.43a | 1.26–4.71 |
Age (years) | ||||
17–20 | –c | –c | –c | –c |
21–22 | 1.11 | 0.33–3.77 | 0.48 | 0.21–1.06 |
≥23 | 0.82 | 0.20–3.34 | 0.51 | 0.19–1.38 |
Country of study | ||||
USA | –c | –c | –c | –c |
Hong Kong | 1.24 | 0.14–11.06 | 0.33 | 0.07–1.58 |
Singapore | 4.59b | 1.13–18.68 | 2.68b | 1.04–6.91 |
Other | 2.80 | 0.72–10.89 | 1.52 | 0.65–3.59 |
Hong Kong residency | ||||
No | –c | –c | –c | –c |
Yes | 0.56 | 0.12–2.69 | 0.46 | 0.17–1.29 |
Compliance with guidelines prior to arrival | ||||
Viewing health organization websites | 1.21a | 1.05–1.39 | 0.95 | 0.85–1.06 |
Offline, practice-based guidelines | 1.36a | 1.15–1.61 | 1.19a | 1.07–1.33 |
Opinions on necessity of measures | ||||
Temperature checkpoints | 1.48a | 1.12–1.97 | 0.79a | 0.67–0.94 |
Contingency measures | 1.00 | 0.87–1.15 | 1.16a | 1.05–1.29 |
CI, confidence interval.
P < 0.001.
P < 0.05.
Reference.